17% Growth, But Profit Growth Stalls—Commodity Inflation Unpriced
Revenue jumped 17.2% to ₹1,134 Cr, but PAT crawled forward just 5.7% to ₹128 Cr. Tariff refunds and delayed price realization mask an underlying margin squeeze that management expects to resolve in H2—but the timing risk is material.
₹128.3 Cr
+5.7% YoY
~₹22 Cr
50–60% of ₹40 Cr total
~₹106 Cr
Commodity inflation unpriced
The quarter sits at an uncomfortable intersection: headline revenue growth of 17.2% should drive PAT expansion, yet profit crept forward just 5.7%. That gap is the story. Strip out the ₹20–24 Cr in tariff refund benefits recognized this quarter—a timing-driven windfall that management defers another 40–50% to H2—and the organic profit picture is materially softer. Underneath lies a company managing through 5% material cost inflation (cumulative ₹820 Cr year-to-date), most of which hasn't yet found its way into customer prices.
Where the profit came from (and where it stalled)
EBITDA came in at ₹185 Cr, translating to a 16.3% margin—solid in isolation. But the operating profit margin of 16.0% ticked up only 60 basis points quarter-over-quarter, a muted recovery despite the tariff refund cushion. The problem: raw material costs outpaced price realization. Q2 saw ₹170 Cr in material cost inflation alone (following ₹650 Cr in Q1). Management pushed price increases in July–August, but 'those corrections,' as leadership put it, 'haven't yet reflected in Q2 results.' That shifted the timeline to Q3–Q4, a slip from the 'end-Q2' guidance cited on the prior call.
Foreign exchange added approximately 4% of revenue growth (INR/USD and EUR favorable), a structural tailwind that won't repeat if the rupee stabilizes. In sum: margin expansion was masked by a one-time tariff benefit; cost inflation remains unpriced; and FX was atypical. Stripped of these, the quarter shows margin compression not recovery.
17% YoY revenue growth
Supported₹1,134 Cr vs prior ~₹968 Cr; 17.2% actual
28% EBITDA YoY growth
Unverified₹185 Cr stated; prior-year absolute not quantified on call
4% of growth from FX, balance volume
SupportedINR/USD and EUR positive; confirmed volume-driven (India 52% growth)
Material costs up ₹170 Cr Q2, ₹650 Cr Q1
SupportedManagement explicitly confirmed; YTD cumulative ~₹820 Cr
₹40 Cr tariff refund, 50–60% in Q2
Supported₹20–24 Cr recognized Q2 in material cost; remainder deferred Q3–Q4
Gross margin recovered ~60bps QoQ
OverstatedOPM 16.0% Q2 vs ~15.4% implied Q1; modest recovery given tariff cushion
What changed on this call
Commodity inflation severity: UPGRADED — ₹820 Cr YTD vs assumed 5% inflation
Vayu launch trajectory: UPGRADED — Order book 'far exceeding expectations' vs initial guidance
Price recovery timing: DOWNGRADED — Now Q3–Q4 FY27, not end-Q2 as prior call indicated
Europe and Australia: HOLDING — Reaffirmed 'marginally profitable' FY27 and stabilization; no upgrade
US aftermarket: UPGRADED — Service income recovery beginning post-Patton acquisition
How the street is positioned
At ₹561.5 (as of 11 November 2026), the stock trades down 29.7% from its all-time high of ₹798.95, though up 37.5% off its 52-week low of ₹408.25. Technically, it sits above the 20-day moving average (₹540.38) but below the 50-day (₹581.19), suggesting intermediate-term indecision; the RSI of 52.6 confirms neutral territory. Volume is trending upward—a sign of interest, though direction remains unclear.
Institutional positioning is shifting. FII ownership has fallen sharply from 27.62% (Q1 FY26) to 21.90% (Q1 FY27)—a 5.7 percentage-point exodus over 12 months. This tracks the margin pressure and guidance misses. Conversely, domestic institutions (DII) have been adding modestly, from 5.23% to 10.13%, suggesting Indian buyer accumulation at lower prices. Promoter ownership remains steady at 31.19%, showing no insider selling near the highs. The FII retreat is the clearest signal: the market shares the call transcript's own tension—long-term opportunity (Vayu, 18% EBITDA target by 2031) is real, but near-term margin recovery is the gate-keeper, and execution risk is material.
The bull–bear ledger
Revenue growth of 17.2% is broad-based and healthy
PAT growth of 5.7% reveals unpriced commodity inflation; narrow profit expansion
Vayu launch 'outstanding,' order book exceeds expectations
Vayu addressable market (25–30% of segment) is known; margin profile is not
Tariff refund ₹40 Cr; 50–60% recognized Q2; boost is one-time and timing-driven
Price increases pushed July–August but not yet reflected in P&L; Q3–Q4 dependent
Long-term 18% EBITDA target (by 2031) is quantified and credible
Europe and Australia restructuring on track but remain profitability plays
Aftermarket emerging; North America service income recovery beginning
FII ownership fallen 5.7pp YoY; domestic institutions accumulating at lower prices
Risks, ranked by how much they should concern a holder
Commodity inflation outpaces 5% assumption; price recovery stalls Q4 or beyond
HIGHMaterial costs have already hit ₹820 Cr YTD. If price increases slip further or customer resistance hardens, margin compression will persist and FY28 guidance will fall.
Europe and Australia profitability recovery slower than 'marginally profitable' FY27 target
MEDIUMMacro headwinds (geopolitical, economies under pressure) could delay restructuring payoff. 50% of growth comes from four geographies; two are under pressure.
Tariff refund balance (40–50% = ₹16–20 Cr) deferred beyond Q4 FY27
MEDIUMCompounds near-term margin pressure if price recovery also delays. Timing-dependent profit boost disappears from P&L.
Vayu cannibalization and margin profile unknown; low-cost segment may compress returns
MEDIUMVayu is intentionally low-margin by design. Scale and pricing strategy unclear. If margins are <10%, overall company EBITDA could face longer-term dilution.
FX headwind if rupee strengthens; 4% of current growth reverses
LOWCurrently a tailwind. Natural hedges likely improve as exports ramp. But a structural shift to rupee strength would reset baseline growth expectations.
What to watch next (the make-or-break catalysts)
1 · Q3 gross margin recovery (the lynchpin)
Will price increases fully offset material cost inflation? This is the single number that validates or falsifies the thesis. If gross margin expands 100+ bps QoQ in Q3, the market re-rates higher. If it stalls or margins compress further, FY27–28 consensus falls and stock doubles down on margin concerns.
2 · Europe and Australia profitability delivery
Reaffirmed 'marginally profitable' FY27 and medium-term profit escalation. Track quarterly EBITDA from these regions. If they miss or retreat, restructuring credibility erodes and long-term 18% EBITDA target becomes uncertain.
3 · Vayu ramp and margin trajectory
Initial launch is 'outstanding.' Watch Q3 order flow, geography coverage (target 35% by September 2026, 100% by January/February 2027), and gross margin per unit. If margins are sub-10%, the market reprices Vayu as a volume story, not a profit story.
This is a company navigating near-term margin pressure with long-term optionality. The Vayu launch and aftermarket opportunity are real, and the 18% EBITDA target by 2031 is credible. But Q2 FY27 exposes the timing risk: 17% revenue growth hasn't translated to profit growth because of unpriced commodity inflation. The quarter is steady execution, not a step-change. Until H2 FY27 delivers on price realization, the market will remain cautious—a stance reflected in the neutral technicals and bifurcated institutional flow.
Hold. The number to track from here is the gross margin in Q3 FY27. That single metric will tell you whether management's confidence on margin recovery is credible or aspirational.
Informational and educational content only. Not investment advice.